UNSPSC 51172314: Pralidoxime

This classification denotes a cholinergic agonist with the molecular formula C7H9N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P7MU9UTP52, chemically known as pyridinium, 2-((hydroxyimino)methyl)-1-methyl-, iodide but generally known as pralidoxime, which bears US NIH Compound Identifier 5353894. European Medicines Agency schedules Pralidoxime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04002MIG.

UNSPSC 51172314 Pralidoxime, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The single recent opportunity—Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services—involves laboratory-based drug screening and confirmation testing (immunoassay, LC/MS/MS, GC/MS) and alternative methodologies (oral fluid, hair testing), not the pharmaceutical compound pralidoxime. The scope includes staffing two collection sites in Plano and McKinney, operating an Interactive Voice Response notification system, and delivering electronic result reporting over a two-year initial term with three optional one-year renewals. The estimated contract value is $600,000, with annual testing demand of approximately 25,031 tests across five-panel and six-panel screening configurations. Lab certification from SAMHSA, TX DPS, or CAP is required. Pricing is per-test across three service models (screening only, confirmation after screening, and screening with automatic confirmation of positives), with freight, delivery, insurance, and staffing included and price redetermination capped at 3.0 percent annually on September 1 anniversaries.

The code shows minimal relevant recent activity for pralidoxime itself. Collin County's drug-testing RFP represents a mismatch between the UNSPSC category assignment and the actual goods and services being procured. No other state or local opportunities under this code appear in the source, and the single posted opportunity offers no signal of broader pralidoxime procurement across state agencies, counties, municipalities, school districts, or transit authorities. Business development professionals evaluating this code should verify whether pralidoxime remains a meaningful procurement category within state and local health or emergency-response procurement, or whether the tagging represents a data-quality issue in the upstream opportunity feed.